Results From the PROGRESS Study of Zilurgisertib in Patients With Fibrodysplasia Ossificans Progressiva by Madaline Spencer| Published on: Jul 27, 2026

Results From the PROGRESS Study of Zilurgisertib in Patients With Fibrodysplasia Ossificans Progressiva by Madaline Spencer| Published on: Jul 27, 2026 Joanne Quan, MD, Chief Medical Officer of Mirum Pharmaceuticals, discusses results from the PROGRESS study of zilurgisertib in patients with fibrodysplasia ossificans progressiva (FOP). https://checkrare.com/results-from-the-progress-study-of-zilurgisertib-in-patients-with-fibrodysplasia-ossificans-progressiva/